切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2015, Vol. 03 ›› Issue (04) : 271 -273. doi: 10.3877/cma.j.issn.2095-655X.2015.04.013

所属专题: 文献

临床研究

17β-羟基类固醇脱氢酶10病的临床诊断并文献复习
盛志强1, 满宜刚1,()   
  1. 1. 272011 济宁市第一人民医院儿童康复科
  • 收稿日期:2015-06-17 出版日期:2015-11-26
  • 通信作者: 满宜刚
  • 基金资助:
    山东省中医药项目(2013-309); 济宁市科技局项目(2013jnwk127)

Diagnosis and literature review of 17β-Hydroxysteroid dehydrogenase 10 disease

Zhiqiang Sheng1, Yigang Man1,()   

  1. 1. Department of Pediatric Rehabilitation, The First People′s Hospital of Jining, Jining 272011, China
  • Received:2015-06-17 Published:2015-11-26
  • Corresponding author: Yigang Man
  • About author:
    Corresponding author: Man Yigang, Email:
引用本文:

盛志强, 满宜刚. 17β-羟基类固醇脱氢酶10病的临床诊断并文献复习[J]. 中华诊断学电子杂志, 2015, 03(04): 271-273.

Zhiqiang Sheng, Yigang Man. Diagnosis and literature review of 17β-Hydroxysteroid dehydrogenase 10 disease[J]. Chinese Journal of Diagnostics(Electronic Edition), 2015, 03(04): 271-273.

目的

探讨17β-羟基类固醇脱氢酶10(HSD10)病的临床诊断学特征。

方法

回顾性分析济宁市第一人民医院儿童康复科收治的1例HSD10病患儿临床资料,并复习文献。

结果

患儿临床表现为精神发育倒退、抽搐、水平性眼球震颤。颅脑磁共振、动态脑电图和血酰基肉碱分析、尿有机酸分析均未见明显异常,心肌酶示谷草转氨酶79.8 U/L、肌酸激酶221 U/L、肌酸激酶同工酶43.5 U/L、乳酸脱氢酶356 U/L、羟丁酸脱氢酶339 U/L;神经心理发育评估示中度智力低下,基因检测示患儿HSD17B10基因在外显子4发生c.388C>T(p.R130C)改变,确诊为HSD10病。

结论

HSD10病主要损害神经系统,表现为明显的精神运动发育迟滞;确诊依赖于基因检测,表现为HSD17B10基因突变。

Objective

To explore the diagnostic features of 17β-Hydroxysteroid dehydrogenase 10 disease(HSD10 disease).

Methods

The clinical data of a 7-months-old infantile who was diagnosed in the First People′s Hospital of Jining was retrospectively analyzed, and relevant literatures were reviewed.

Results

The boy was mainly presented with neurodegeneration, convulsion, and horizontal nystagmus.The cerebral magnetic resonance imaging and the ambulatory electroencephalogram were negative.The blood acylcarnitine and urinary organic acid analysis were normal.The concentrations of serum myocardial enzymes increased, including glutamic oxalocetic transaminase (79.8U/L), creatine kinase (221U/L), creatine kinase isoenzyme MB (43.5U/L), lactate dehydrogenase (356U/L), hydroxybutyric dehydrogenase (339U/L). The neurological development was moderate mental retardation.The diagnosis was confirmed by molecular genetic study of the gene HSD17B10.The patient was hemizygous for the previously described mutation p. R130C (c.388C>T).

Conclusions

HSD10 disease mainly damages the nervous system.Affected patients show a progressive neurodegenerative disease course.Confirmation of the diagnosis is based on the identification of a disease-causing mutation in the HSD17B10 gene.

[1]
Zschocke, J.HSD10 disease:clinical consequences of mutations in the HSD17B10 gene[J]. J Inherited Metab Dis, 2012, 35(1): 81-89.
[2]
Zschocke J,Ruiter JPN,Brand J, et al.Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deciency:a novel inborn error of branched-chain fatty acid and isoleucine catabolism[J]. Pediatr Res, 2000, 48(6): 852-855.
[3]
Ensenauer R,Niederhoff H,Ruiter JP, et al.Clinical variability in 3-hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency[J]. Ann Neurol, 2002, 51(5): 656-659.
[4]
Olpin SE,Pollitt RJ,McMenamin J, et al.2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man[J]. J Inherit Metab Dis, 2002, 25(6): 477-482.
[5]
Sutton VR,O’Brien WE,Clark GD, et al.3-Hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency[J]. J Inherit Metab Dis, 2003, 26(1): 69-71.
[6]
Sass JO,Forstner R,Sperl W. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency:impaired catabolism of isoleucine presenting as neurodegenerative disease[J]. Brain Dev, 2004, 26(1): 12-14.
[7]
Poll-The BT,Wanders RJ,Ruiter JP, et al.Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases[J]. Mol Genet Metab, 2004, 81(4): 295-299.
[8]
Perez-Cerda C,Garcia-Villoria J,Ofman R, et al.2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency:an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease[J]. Pediatr Res, 2005, 58(3): 488-491.
[9]
Cazorla MR,Verdu A,Perez-Cerda C, et al.Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency[J]. Pediatr Neurol, 2007, 36(4): 264-267.
[10]
Lenski C,Kooy RF,Reyniers E, et al.The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior[J]. Am J Hum Genet, 2007, 80(2): 372-377.
[11]
Garcia-Villoria J,Navarro-Sastre A,Fons C, et al.Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoAdehydrogenase(MHBD) deficiency:difficulties in the diagnosis[J]. Clin Biochem, 2009, 42(1-2): 27-33.
[12]
Rauschenberger K,Schöler K,Sass JO, et al.A non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival[J]. EMBO Mol Med, 2010, 2(2): 51-62.
[13]
Seaver LH,He XY,Abe K, et al.A novel mutation in the HSD17B10 gene of a 10-year-old boy with refractory epilepsy, choreoathetosis and learning disability[J]. PLoS One, 2011, 6(11), e27348.
[14]
舒剑波,张玉琴,姜淑贞, 等.2甲基3羟基丁酰辅酶A脱氢酶缺陷症一家系基因突变分析[J]. 中华儿科杂志, 2013, 51(10): 783-786.
[15]
Fukao T,Akiba K,Goto M , et al.The first case in Asia of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (HSD10 disease) with atypical presentation.Journal of Human Genetics[J]. J Hum Genet, 2014, 59(9): 521-528.
[16]
满宜刚,盛志强. 婴儿痉挛征患儿智能结构变化对综合康复训练效果的判断价值[J/CD]. 中华诊断学电子杂志, 2014, 2(4): 298-300.
[17]
Korman SH,Yang SY.HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency[J]. Mol Genet Metab, 2007, 91(1): 115.
[18]
He XY,Merz G,Yang YZ, et al.Characterization and localization of human type10 17beta hydroxysteroid dehydrogenase[J]. Eur J Biochem, 2001, 268(18): 4899-4907.
[19]
Yang SY,He XY,Isaacs C, et al.Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders[J]. J Steroid Biochem Mol Biol, 2014, 143: 460-472.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[3] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[4] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
[5] 李晓阳, 刘柏隆, 周祥福. 大数据及人工智能对女性盆底功能障碍性疾病的诊断及风险预测[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 549-552.
[6] 许丁伟, 马江云, 李新成, 黄洁. Alagille综合征疑诊为先天性胆道闭锁一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 681-687.
[7] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[8] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[9] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[10] 赵立力, 王魁向, 张小冲, 李志远. 血沉与C-反应蛋白比值在假体周围感染中的诊断价值分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 351-355.
[11] 吴凤芸, 滕鑫, 刘连娟. 高帧频超声造影与增强磁共振对不同直径原发性高分化肝细胞癌的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 404-408.
[12] 孙欣欣, 刘军, 陈超伍, 孙超. 超声内镜引导细针穿刺抽吸术在胰腺占位性病变中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 418-421.
[13] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[14] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[15] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
阅读次数
全文


摘要